“Validation of A Genomic Classifier That Predicts Metastatic Disease Progression in Men With Biochemical Recurrence Post Radical Prostatectomy”, in American Society of Clinical Oncology, Genitourinary Cancers Symposium, Orlando, FL, 2013.
, “Validation of a Genomic Classifier That Predicts Metastatic Disease Rogression in Men with Biochemical Recurrence Post Radical Prostatectomy”, in American Society of Clinical Oncology (ASCO) 2013, Chicago, IL, 2013.
, “Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.”, J Urol, vol. 190, no. 6, pp. 2047-53, 2013.
, “Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an at Risk Patient Population”, J Urol, vol. 190, pp. 2047-2053, 2013.
, “Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial.”, JAMA Oncol, vol. 7, no. 4, pp. 544-552, 2021.
, “Validation and human factor analysis study of an infant weight estimation device.”, BMC Pediatr, vol. 20, no. 1, p. 30, 2020.
, “Vaccine-related major cutaneous reaction size correlates with cellular-mediated immune responses after tularaemia immunisation.”, Clin Transl Immunology, vol. 10, no. 1, p. e1239, 2021.
, “A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials.”, Sci Transl Med, vol. 11, no. 507, 2019.
, “Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.”, Nature, vol. 482, no. 7383, pp. 89-93, 2012.
, “Vaccine Protection Against Acquisition of Neutralization-Resistant SIV Challenges in Rhesus Monkeys”, Nature, vol. 482, pp. 89-93, 2012.
, “Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.”, N Engl J Med, vol. 361, no. 23, pp. 2209-20, 2009.
, “Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand”, N Engl J Med, vol. 361, pp. 2209-2220, 2009.
, “Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial.”, JAMA, vol. 292, no. 10, pp. 1205-12, 2004.
, “Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine”, J Amer Med Assn, vol. 292, pp. 1205-1212, 2004.
, ,
“Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.”, J Addict Med, vol. 10, no. 4, pp. 236-43, 2016.
, “Utility of Targeted Gene Sequencing to Differentiate Myeloid Malignancies from other Cytopenic Conditions”, Blood Adv, 2023.
, , “Using Good Clinical Practice in Ophthalmic Photography: The Clinical Research Organization's Role in Ophthalmic Photography”, in Ophthalmic Photographers' Society, Bethesda, MD, 2007.
, “Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study.”, Contemp Clin Trials, vol. 46, pp. 30-38, 2016.
, “Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data.”, Brief Bioinform, vol. 12, no. 3, pp. 203-14, 2011.
, “Using Cross-Validation to Evaluate Predictive Accuracy of Survival Risk Classifiers Based on High-Dimensional Data”, Brief Bioinformatics, vol. 12, pp. 203-214, 2011.
, “Usefulness of the Atrial Emptying Fraction to Predict Maintenance of Sinus Rhythm After Direct Current Cardioversion for Atrial Fibrillation.”, Am J Cardiol, vol. 118, no. 9, pp. 1345-1349, 2016.
, “Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.”, J Oncol Pract, vol. 10, no. 2, pp. e73-80, 2014.
, “Use of the National Cancer Institute Community Cancer Centers Program Screening and Accrual Log to Address Cancer Clinical Trial Accrual”, J Oncol Pract, vol. 10, pp. e73-e80, 2014.
,